Lab biologists Mike Malfatti and Heather Enright look at liquid chromatography/mass spectrometry data from an analysis of subedatex and fentanyl in tissue.
LLNL biologists David Baliu-Rodriguez (left) and Mike Malfatti examine the Accelerator Mass Spectrometry results showing the quantification of carbon-14 labeled-subedatex in tissue.
Carlos Valdez, a chemist and the principal investigator for the fentanyl medical countermeasure initiative, prepares to analyze a mixture of the synthetic opioid fentanyl and subedatex using nuclear magnetic resonance.